Draft Guidances Address Device Cybersecurity, Nonprescription Drug Labeling Changes

Manufacturers of cyber devices must have a plan to keep those devices secure for the product’s entire lifecycle, and sponsors of nonprescription drugs can include some minor labeling changes on an annual report, according to two new draft guidances issued by the FDA.
Source: Drug Industry Daily